Drug Sales in Emerging Markets to Match U.S. by 2016

by Blog Burger on July 12, 2012

China, India, Brazil, Russia and 12 other emerging markets will make up almost one-third of global pharmaceutical spending within four years, as newly wealthy people and nations spend more on health care, a report shows. Rising drug spending in 16 emerging pharmaceutical markets will lead the industry‚Äôs global sales growth by 2016, according to a report released today by the IMS Institute for Healthcare Informatics, a Parsippany, New Jersey-based research arm of drug sales analysis firm IMS Health Inc. As emerging markets grow, European government budget cuts and drugs losing U.S. patent…

WN.com – Science News

Comments on this entry are closed.

Previous post:

Next post: